Does the alpha-defensin lateral flow test conserve its diagnostic properties in a larger population of chronic complex periprosthetic infections? Enlargement to 112 tests, from 42 tests in a preliminary study, in a reference center - 20/05/21
, Pierre Martinot a, b, c, Adrien Pascal a, b, c, Eric Senneville a, b, d, Caroline Loiez a, b, e, Gilles Pasquier a, b, c, Julien Girard a, b, c, f, Sophie Putman a, b, c, Henri Migaud a, b, c
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
Diagnosis of periprosthetic infection (PPI) is crucial for management of bone and joint infection. The preoperative gold-standard is joint aspiration, providing results after 2-14 days’ culture, with non-negligible false negative rates due to the fragility of certain micro-organisms and/or prior antibiotic treatment. The Synovasure™ alpha-defensin lateral flow test (Zimmer, Warsaw, IN, USA) contributes within minutes to joint fluid diagnosis of almost all infectious agents, including in case of concomitant antibiotic therapy. Validity remains controversial, notably in complex microbiological situations: multi-operated patients, diagnostic doubt despite iterative sterile culture, long-course antibiotic therapy. We extended a prospective study reported in 2018, to determine whether the test maintained diagnostic value in a larger population, assessing 1) negative (NPV) and positive (PPV) predictive value, and 2) sensitivity and specificity.
Hypothesis |
Synovasure™ maintains NPV above 95% in a broader population of microbiologically complex suspected PPI.
Material and methods |
Synovasure™’s performance was assessed between October 2015 and October 2019 in 106 patients (112 tests) in complex diagnostic situations: 37 discordant cultures (discordant findings between 2 samples), 65 cases with clinically or biologically suspected infection but iterative sterile culture, 10 emergencies (requiring surgery, precluding antibiotic window, or mechanical failure in suspected infection), including 5 with ongoing antibiotic therapy for infection in another organ. Six tests were repeated in the same patient and same joint at >6 months’ interval for strong clinical suspicion of infection. The main endpoint was the MSIS score (MusculoSkeletal Infection Society, 2018).
Results |
NPV was 98.8%, PPV 72.4%, sensitivity 95.5% and specificity 91%. Prevalence of infection was 19.6%. Only 1 of the 22 infected patients had negative Synovasure™ tests, compared to 81 of the 84 non-infected patients.
Conclusion |
Synovasure™ is a reliable novel diagnostic test, contributing mainly to ruling out infection thanks to its strong NPV. The cost imposes sparing use, but medico-economic assessment would be worthwhile.
Level of evidence |
III; prospective of diagnostic performance.
Le texte complet de cet article est disponible en PDF.Keywords : Periprosthetic infection, Synovasure, Alpha defensin, MSIS, Infection diagnosis, Bone and joint infection
Plan
Vol 107 - N° 4
Article 102912- juin 2021 Retour au numéro
Article précédent
- Low value of platelet count to mean platelet volume ratio to diagnose chronic PJI: A case control study
- Erdem Sahin, Bedri Karaismailoglu, Mahmut Kursat Ozsahin, Mehmet Fatih Guven, Gokhan Kaynak
- A comparison of short term complication rate between 44 two- and 385 one-stage septic exchange arthroplasties in chronic periprosthetic joint infections
- Darius M. Thiesen, Human Sobhani, Thorsten Gehrke, Eduardo M. Suero, Till O. Klatte, Mustafa Citak
Bienvenue sur EM-consulte, la référence des professionnels de santé.